Innovative CDMO Solutions in an Ever-Changing World
Asymchem is a global contract development and manufacturing organization (CDMO) founded in 1999, providing integrated R&D and one-stop production services to the world's top pharmaceutical companies. The company offers comprehensive CMC services covering the full lifecycle of drug development — from early clinical stage through commercial manufacturing — including advanced intermediates, APIs, formulations, and clinical research services. Asymchem is a recognized leader in green chemistry and novel manufacturing technologies including continuous flow chemistry, biocatalysis, fermentation, and electrochemistry, enabling cost-effective and environmentally responsible pharmaceutical synthesis.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2021
Feb 2020
Aug 2011
Create a free account to see which investors have funded this company.
Create Free AccountClinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Global biosimulation software and services company accelerating drug development for 2,000+ bioph...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
